6th Jan 2005 13:35
Allergy Therapeutics PLC06 January 2005 Schedule 10 NOTIFICATION OF MAJOR INTERSTS IN SHARES 1. Name of Company Allergy Therapeutics plc 2. Name of shareholder having a major interest Baillie Gifford & Co. 3. Please state whether notification indicates that it is inrespect of holding of the shareholder names in 2 above or in respect of anon-beneficial interest or in the case of children under the age of 18 ......................................................... 4. Name of the registered holder(s) and, if more than one holder, the number of share held by each of them RBS Dep Bg British Sml Co Fd (oeic) under BNY (OCS) Nominees Limited 5. Number of shares/amount of stock acquired 2,054,795 6. Percentage of issued class 3.26% 7. Number of shares/amount of stock disposed ......................................................... 8. Percentage of issued class ......................................................... 9. Class of security Ordinary Shares 10. Date of transaction 12/10/2004 11. Date company informed 04/01/2005 12. Total holding following this notification 2,054, 795 13. Total percentage holding of issued class following this notification 3.26% 14. Any additional items ........................................................ 15. Name of contact and telephone number for queries Ian Postlethwaite - 01903 844721 16. Name and signature of authorised company official responsible for make this notification Ian Postlethwaite .............................................. Date of notification 06/01/2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept liability for error or omission. TheFSA is not liable for any damages (including, without limitation, damages forloss of business or loss of profits) arising in contract, tort or otherwise fromthe use of or inability to use this document, or any material contained in it,or from any action or decision taken as a result of using this document or anysuch material. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.